“IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?”. 2021. Mediterranean Journal of Hematology and Infectious Diseases 13 (1): e2021062. https://doi.org/10.4084/MJHID.2021.062.